Medical Properties Trust, Inc. (NYSE:MPW) Position Trimmed by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. trimmed its position in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 14.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 19,500 shares of the real estate investment trust’s stock after selling 3,176 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Medical Properties Trust were worth $114,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. Future Financial Wealth Managment LLC acquired a new stake in shares of Medical Properties Trust during the 3rd quarter valued at about $29,000. Versant Capital Management Inc lifted its holdings in Medical Properties Trust by 435.0% in the 2nd quarter. Versant Capital Management Inc now owns 7,972 shares of the real estate investment trust’s stock worth $34,000 after purchasing an additional 6,482 shares during the last quarter. Iron Horse Wealth Management LLC lifted its holdings in Medical Properties Trust by 166.7% in the 2nd quarter. Iron Horse Wealth Management LLC now owns 8,000 shares of the real estate investment trust’s stock worth $34,000 after purchasing an additional 5,000 shares during the last quarter. GAMMA Investing LLC lifted its holdings in Medical Properties Trust by 107.3% in the 3rd quarter. GAMMA Investing LLC now owns 6,077 shares of the real estate investment trust’s stock worth $36,000 after purchasing an additional 3,145 shares during the last quarter. Finally, Gateway Investment Advisers LLC acquired a new stake in Medical Properties Trust in the 2nd quarter worth approximately $45,000. 71.79% of the stock is currently owned by institutional investors and hedge funds.

Medical Properties Trust Stock Performance

MPW opened at $4.31 on Friday. The stock’s 50 day simple moving average is $5.03 and its 200-day simple moving average is $4.90. Medical Properties Trust, Inc. has a 1 year low of $2.92 and a 1 year high of $6.55. The stock has a market cap of $2.59 billion, a PE ratio of -1.02, a P/E/G ratio of 0.65 and a beta of 1.32. The company has a current ratio of 2.38, a quick ratio of 2.38 and a debt-to-equity ratio of 1.69.

Medical Properties Trust Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, January 9th. Shareholders of record on Thursday, December 12th will be given a $0.08 dividend. This represents a $0.32 dividend on an annualized basis and a yield of 7.42%. The ex-dividend date is Thursday, December 12th. Medical Properties Trust’s dividend payout ratio (DPR) is -7.58%.

Insider Buying and Selling at Medical Properties Trust

In other Medical Properties Trust news, Director C Reynolds Thompson III sold 20,530 shares of the business’s stock in a transaction on Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total value of $89,921.40. Following the transaction, the director now owns 54,637 shares of the company’s stock, valued at approximately $239,310.06. The trade was a 27.31 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Michael G. Stewart sold 32,780 shares of the business’s stock in a transaction on Wednesday, October 9th. The stock was sold at an average price of $5.46, for a total value of $178,978.80. Following the completion of the transaction, the director now directly owns 221,245 shares in the company, valued at approximately $1,207,997.70. This represents a 12.90 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.53% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Wolfe Research upgraded Medical Properties Trust to a “hold” rating in a report on Monday, September 23rd. Colliers Securities upgraded Medical Properties Trust from a “neutral” rating to a “buy” rating and set a $6.50 target price for the company in a report on Friday, September 13th. Finally, Truist Financial boosted their target price on Medical Properties Trust from $5.00 to $6.00 and gave the stock a “hold” rating in a report on Friday, September 13th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $5.50.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.